Comparative relaxant effects of YC-1 and DEA/NO on the sheep sphincter of Oddi

Pancreatology

Volumn 6, Issue 3, 2006, Pages 215-219

  Bagcivan, Ihsan ^a   Kaya, Tijen ^a   Turan, Mustafa ^a   Karadas, Baris ^a   Sarac, Bülent ^a   Duman, Mustafa ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

DEA NO; Relaxation; Sphincter of Oddi; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CARBACHOL; CYCLIC GMP; DIETHYLAMINE; GUANYLATE CYCLASE ACTIVATOR; NITRIC OXIDE DONOR;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; ODDI SPHINCTER; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

EID: 33746334720     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000091959     Document Type: Article

References (24)

1. Mawe GM: Oddi: The structure of Oddi's sphincter; in Daniel EE, Tsuchida S, Tomita T (eds): Sphincter: Normal Function Changes in Diseases. Boca Raton, CRC Press, 1992, pp 175-187.
2. Baker RA, Saccone GT, Brookes SJ, Toouli J: Nitric oxide mediates nonadrenergic, noncholinergic neural relaxation in the Australian possum. Gastroenterology 1993;105:1746-1753.
3. Takahashi T: Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 2003;38:421-430.
4. Kaufmann HS, Shermak MA, May CA, Pitt HA: Nitric oxide inhibits resting sphincter of Oddi activity. Am J Surg 1993;165:74-80.
5. Mourelle M, Guarner F, Moncada S, Malagelada JR: The arginine/nitric oxide pathway modulates sphincter of Oddi motor activity in guinea pigs and rabbits. Gastroenterology 1993;105:1299-1305.
6. Cullen JJ, Conklin JL, Murray J, Ledlow A, Rosenthal G: Effects of recombinant human hemoglobin on opossum sphincter of Oddi motor function in vivo and in vitro. Dig Dis Sci 1996;41:289-294.
7. Slivka A, Chuttani R, Carr-Locke DL, Kobzik L, Bredt DS, Loscalzo J, Stamler JS: Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest 1994;94:1792-1798.
8. Luman W, Pryde A, Heading RC, Palmer KR: Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut 1997;40:541-543.
9. Koesling D, Friebe A: Soluble guanylyl cyclase: Structure and regulation. Rev Physiol Biochem Pharmacol 1999;135:35-41.
10. Morley D, Keefer LK: Nitric oxide/nucleophile complexes: A unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993;22:3-9.
11. Cetin A, Kaya T, Demirkoprulu N, Karadas B, Duran B, Cetin M: YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium. J Pharmacol Sci 2004;94:19-24.
12. Hsieh GC, O'Neill AB, Moreland RB, Sullivan JP, Brioni JD: YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats. Eur J Pharmacol 2003;458:183-189.
13. Salom JB, Barbera MD, Centeno JM, Orti M, Torregrosa G, Alborch E: Comparative relaxant effects of the NO donors sodium nitroprusside, DEA/NO and SPER/NO in rabbit carotid arteries. Gen Pharmacol 1999;32:75-79.
14. Jenkinson DH, Barnard EA, Hoyer D, Humphrey PP, Leff P, Shankley NP: International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev 1995;47:255-266.
15. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG: Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990;345:346-347.
16. Stark ME, Szurszewski JH: The role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1991;103:1928-1949.
17. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
18. Szilvassy Z, Nagy I, Madacsy L, Hajnal F, Velosy B, Takacs T, Lonovics J: Beneficial effect of lovastatin on sphincter of Oddi dyskinesia in hypercholesterolemia and hypertriglyceridemia. Am J Gastroenterol 1997;92:900-902.
19. Walter U: Cyclic GMP-regulated enzymes and their physiological functions; in Greengard P, Robinson AG (eds): Advances in Cyclic Nucleotide Research and Protein Phosphorylation Research. Raven Press, New York, 1999, pp 249-258.
20. Sand J, Arvola P, Jantti V, Oja S, Singaram C, Baer G, Pasricha PJ, Nordback I: The inhibitory role of nitric oxide in the control of porcine and human sphincter of Oddi activity. Gut 1997;41:375-380.
21. Niiyama H, Jagannath S, Kantsevoy S, Cruz-Correa M, Magee C, Kalloo AN: Intrasphincteric nitric oxide reduces sphincter of Oddi motility in an endoscopic porcine model. Dig Dis Sci 2003;48:2187-2190.
22. Ignarro LJ, Barry BK, Gruetter DY, Edwards JC, Ohlstein EH, Gruetter CA, Baricos WH: Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates. Biochem Biophys Res Commun 1980;14:93-100.
23. Kowaluk EA, Seth P, Fung HL: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 1992;262:916-922.
24. Okawa T, Sato A, Syal AS, Vedernikov YP, Saade GR, Garfield RE: Effects of nitric oxide donors on non-pregnant and pregnant rat uterine and aortic smooth muscle. Fukushima J Med Sci 2003;49:23-32.